Category Archives: health market quality

The Vitality Institute: Investing In Prevention – A National Imperetive

Vitality absolutely smash it across the board…

  • Investment
  • Leadership
  • Market Creation
  • Developing Health Metrics
  • Everything…!

Must get on to these guys…..

PDF: Vitality_Recommendations2014_Report

PDF: InvestingInPrevention_Slides

Presentation: https://goto.webcasts.com/viewer/event.jsp?ei=1034543 (email: blackfriar@gmail.com)

 

From Forbes: http://www.forbes.com/sites/brucejapsen/2014/06/18/how-corporate-america-could-save-300-billion-by-measuring-health-like-financial-performance/

Bruce Japsen, Contributor

I write about health care and policies from the president’s hometown

How Corporate America Could Save $300 Billion By Measuring Health Like Financial Performance

The U.S. could save more than $300 billion annually if employers adopted strategies that promoted health, prevention of chronic disease and measured progress of “working-age” individuals like they did their financial performance, according to a new report.

The analysis, developed by some well-known public health advocates brought together and funded by The Vitality Institute, said employers could save $217 billion to $303 billion annually, or 5 to 7 percent of total U.S. annual health spending by 2023, by adopting strategies to help Americans head off “non-communicable” diseases like cancer, diabetes, cardiovascular and respiratory issues as well as mental health.

To improve, the report’s authors say companies should be reporting health metrics like BMI and other employee health statuses just like they regularly report earnings and how an increasing number of companies report sustainability. Corporations should be required to integrate health metrics into their annual reporting by 2025, the Vitality Institute said. A link to the entire report and its recommendations is here. 

“Companies should consider the health of their employees as one of their greatest assets,” said Derek Yach, executive director of the Vitality Institute, a New York-based organization funded by South Africa’s largest health insurance company, Discovery Limited.

Those involved in the report say its recommendations come at a time the Affordable Care Act and employers emphasize wellness as a way to improve quality and reduce costs.

“Healthy workers are more productive, resulting in improved financial performance,” Yach said. “We’re calling on corporations to take accountability and start reporting health metrics in their financial and sustainability reports.  We believe this will positively impact the health of both employees and the corporate bottom line.”

The Institute brought together a commission linked here that includes some executives from the health care industry and others who work in academia and business. Commissioners came from Microsoft (MSFT);  the Robert Wood Johnson Foundation; drug and medical device giant Johnson & Johnson (JNJ); health insurer Humana (HUM); and the U.S. Department of Health and Humana Services.

The Vitality Institute said up to 80 percent of non-communicable diseases can be prevented through existing “evidence-based methods” and its report encourages the nation’s policymakers and legislative leaders to increase federal spending on prevention science at least 10 percent by 2017.

“Preventable chronic diseases such as lung cancer, diabetes and heart disease are forcing large numbers of people to exit the workforce prematurely due to their own poor health or to care for sick relatives,” said William Rosenzweig, chair of the Vitality Institute Commission and an executive at Physic Ventures, which invests in health and sustainability projects. “Yet private employers spend less than two percent of their total health budgets on prevention.  This trend will stifle America’s economic growth for decades to come unless health is embraced as a core value in society.”

Lap banding not as neat as it sounds with a 20% revision rate…

 

https://www.mja.com.au/insight/2014/22/high-lap-band-surgery-revision

High lap band surgery revision

Nicole MacKee
Monday, 23 June, 2014
High lap band surgery revision

AN Australian pioneer of bariatric surgery says laparoscopic adjustable gastric banding remains preferable to gastric bypass as a primary bariatric procedure, despite findings that almost 20% of patients will require revisional surgery within 3 years.

Professor Paul O’Brien, emeritus director of Monash University’s Centre for Obesity Research and Education, said he would like the revision rate to be lower, but the procedure was “still good health care”.

“You can’t expect to treat a chronic disease — a lifetime disease — with a single treatment and then walk away and never have to worry about it again”, he said.

An Australian analysis of Medicare data for more than 6000 patients undergoing laparoscopic adjustable gastric band (LAGB) surgery in 2005–2006, published in JAMA Surgery, found that the rate of revisional surgery was 18.9 events per 100 patients, comprising 11.4 intra-abdominal and 7.5 subcutaneous surgical procedures. (1)

JAMA Surgery also published the findings of a French retrospective review of 831 patients who had a primary gastric bypass and 177 patients who had a secondary gastric bypass after failed LAGB. The researchers found similar rates of major adverse outcomes in both groups — 7.8% in the primary procedure group and 8.5% in the secondary procedure group. (2)

A commentary accompanying  the French study said that a higher rate of revisions required after LAGB compared with Roux-en-Y gastric bypass was driving an increase in the number of conversions from LAGB to other interventions, including sleeve gastrectomy, gastric bypass and duodenal switch. (3)

Professor O’Brien said the French study made the important point that there was no difference in safety for a patient having a revision of a gastric bypass or a patient having a primary gastric bypass. However, he said, in Australia it was far more common for LAGB patients requiring revision to have the problem with the band fixed rather than having more invasive gastric bypass.

“Every operation will have a revisional surgery rate and it becomes a surgical decision as to whether you revise to fix it up … or you go to something else”, he said.

The Australian analysis found that conversions to other bariatric procedures (1.3 events per 100 patients) and LAGB reversals (1.9 events per 100 patients) were uncommon here.

Professor O’Brien said the French study showed that for primary gastric bypass as well as secondary gastric bypass after failed adjustable gastric banding, there were some serious risks.

“You’ve got a [hospital] length of stay of 5–6 days, you’ve got a leak rate of 12 patients [= 1008], you have a total of five deaths. You’ve got rate of abdominal reoperation within 30 days of 6%. This is serious stuff”, he said.

LAGB revision could be a day procedure with “a high probability of being very safe and, in our experience, a high probability of as good a weight loss as you get with the other procedures”, said Professor O’Brien, citing research, on which he was lead author, which found that 47% excess weight loss was maintained 15 years postprocedure, regardless of whether revision surgery was required. (4)

Professor John Dixon, head of clinical obesity research at Baker IDI Heart and Diabetes Institute, said there had been “tremendous advances” in the safety of bariatric surgery in recent years, but the reoperation rates for all procedures remained too high.

“All [bariatric procedures] are associated with what we can say is a high reoperation rate that we would like to reduce so that it minimises people’s risk of having to have multiple operations”, he said.

However, he said, while the reoperation rate was “a nuisance”, it should not detract from the overall improvement to health and quality of life provided by these procedures.

“We have to recognise that these are surgical procedures that are essential for many of our patients, they produce a total change in their life”, he said.

Professor Dixon advised GPs to keep a close eye on patients who have had bariatric surgery for any gastrointestinal symptoms and for nutritional deficiencies, which could also result from the procedures.

“If you’re seeing symptoms that worry you … always involve a bariatric surgeon. There have been some major issues when patients have gone to a general surgeon or a gastroenterologist for symptoms that are related to complications of their bariatric surgery”, he said.

 

1. JAMA Surg 2014; Online 18 June 
2. JAMA Surg 2014; Online 18 June 
3. JAMA Surg 2014; Online 18 June 
4. Ann Surg 2013; 257: 87-94

Relman Obit: the medical-industrial complex

RelmanOnHealthcare

http://t.co/g9LnZnM5ta

“Many people think that doctors make their recommendations from a basis of scientific certainty, that the facts are very clear and there’s only one way to diagnose or treat an illness,” he told the review. “In reality, that’s not always the case. Many things are a matter of conjecture, tradition, convenience, habit. In this gray area, where the facts are not clear and one has to make certain assumptions, it is unfortunately very easy to do things primarily because they are economically attractive.”

Photo

Dr. Arnold S. Relman in 1979 at The New England Journal of Medicine. He led it for 23 years.CreditAssociated Press
Dr. Arnold S. Relman, who abandoned the study of philosophy to rise to the top of the medical profession as a researcher, administrator and longtime editor of The New England Journal of Medicine, which became a platform for his early and influential attacks on the profit-driven health care system, died at his home in Cambridge, Mass., on Tuesday, his 91st birthday.

His wife, Dr. Marcia Angell, said the cause wasmelanoma.

Dr. Relman and Dr. Angell filled top editorial posts at the journal for almost a quarter-century, becoming “American medicine’s royal couple,” as the physician and journalist Abigail Zuger wrote in The New York Times in 2012.

The couple shared a George Polk Award, one of journalism’s highest prizes, for an article in 2002 in The New Republic that documented how drug companies invest far more in advertising and lobbying than in research and development.

His extended critique of the medical system was just one facet of a long and accomplished career. Dr. Relman was president of the American Federation for Clinical Research, the American Society of Clinical Investigation and the Association of American Physicians — the only person to hold all three positions. He taught and did research at Boston University, the University of Pennsylvania, Oxford and Harvard, where he was professor emeritus of medicine and social medicine.

Early in his career, he did pioneering research on kidney function.

He was also editor of The Journal of Clinical Investigation, a bible in its field, and he wrote hundreds of articles, for both professional journals and general-interest publications. Days before he died, Dr. Relman received the galleys of his final article, a review of a book on health care spending for The New York Review of Books, to which he was a frequent contributor.

In a provocative essay in the New England journal on Oct. 23, 1980, Dr. Relman, the editor in chief, issued the clarion call that would resound through his career, assailing the American health care system as caring more about making money than curing the sick. He called it a “new medical-industrial complex” — a deliberate analogy to President Dwight D. Eisenhower’s warning about a “military-industrial complex.”

His targets were not the old-line drug companies and medical-equipment suppliers, but rather a new generation of health care and medical services — profit-driven hospitals and nursing homes, diagnostic laboratories, home-care services, kidney dialysis centers and other businesses that made up a multibillion-dollar industry.

“The private health care industry is primarily interested in selling services that are profitable, but patients are interested only in services that they need,” he wrote. In an editorial, The Times said he had “raised a timely warning.”

In 2012, asked how his prediction had turned out, Dr. Relman said medical profiteering had become even worse than he could have imagined.

His prescription was a single taxpayer-supported insurance system, likeMedicare, to replace hundreds of private, high-overhead insurance companies, which he called “parasites.” To control costs, he advocated that doctors be paid a salary rather than a fee for each service performed.

Dr. Relman recognized that his recommendations for repairing the health care system might be politically impossible, but he insisted that it was imperative to keep trying. Though he said he was glad that the health care law signed by President Obama in 2010 enabled more people to get insurance, he saw the legislation as a partial reform at best.

The health care system, he said, was in need of a more aggressive solution to fundamental problems, which he had discussed, somewhat philosophically, in an interview with Technology Review in 1989.

“Many people think that doctors make their recommendations from a basis of scientific certainty, that the facts are very clear and there’s only one way to diagnose or treat an illness,” he told the review. “In reality, that’s not always the case. Many things are a matter of conjecture, tradition, convenience, habit. In this gray area, where the facts are not clear and one has to make certain assumptions, it is unfortunately very easy to do things primarily because they are economically attractive.”

Dr. Relman edited The New England Journal of Medicine from 1977 to 1991. Founded in 1812, it is the oldest continuously published medical journal in the world, reaching more than 600,000 readers a week. Dr. Angell was the editor in 1999 and 2000.

When he took the journal’s helm, interest in health news was booming, and newspapers and magazines competed to be first in reporting new developments. One policy he instituted was to ask general-interest publications not to disclose a forthcoming article in advance, a request almost always honored, albeit sometimes grudgingly.

He also began requiring authors to disclose any financial arrangements that could affect their judgment in writing about the medical field, including consultancies and stock ownership.

Dr. Relman and Dr. Angell met when she was a third-year student and he was a professor at Boston University School of Medicine. They published a paper on kidney disease together in The New England Journal of Medicine, then did not see each other for years.

After he became the journal’s editor, he asked her to come on board as an editor, which she did, abandoning her career as a pathologist. They began living together in 1994 — both were divorced by then — and married in 2009.

They became the ultimate medical power couple, not least because they were gatekeepers for one of the world’s most prestigious medical journals. Their outspoken views further distinguished them.

“Some have dismissed the pair as medical Don Quixotes, comically deluded figures tilting at benign features of the landscape,” Dr. Zuger wrote in The Times. “Others consider them first responders in what has become a battle for the soul of American medicine.”

Arnold Seymour Relman was born on June 17, 1923, in Queens (in an elevator, according to Dr. Angell) and grew up in the Far Rockaway neighborhood. His father was a businessman and avid reader who inspired his son’s love of philosophy. His mother nicknamed him Buddy, and friends called him Bud the rest of his life.

He skipped grades in school and graduated at 19 from Cornell with a degree in philosophy, but he chose not to pursue the field because it “seemed sort of too arcane,” his wife said. He earned a medical degree from the Columbia University College of Physicians and Surgeons at 22. His first marriage was to Harriet M. Vitkin.

In addition to Dr. Angell, he is survived by his sons, David and John, and a daughter, Margaret R. Batten, all from his first marriage; his stepdaughters, Dr. Lara Goitein and Elizabeth Goitein; six granddaughters; and four stepgrandsons.

Last June, Dr. Relman fell down a flight of stairs and cracked his skull, broke three vertebrae in his neck and broke more bones in his face. When he reached the emergency room, surgeons cut his neck to connect a breathing tube. His heart stopped three times.

“Technically, I died,” he told The Boston Globe.

He went on to write an article about his experience for The New York Review of Books, offering the unusual perspective of both a patient and a doctor.

“It’s both good and bad to be a doctor and to be old and sick,” he told The Globe.

“You learn to make the most of it,” he added. “Schopenhauer, the German philosopher, said life is slow death. Doctors learn to accept that as part of life. Although we consider death to be our enemy, it’s something we know very well, and that we deal with all the time, and we know that we are no different. My body is just another body.”

Correction: June 23, 2014 
An earlier version of this obituary misstated where Dr. Relman and his wife, Dr. Marcia Angell, met. They met when she was a student and he was a professor at Boston University School of Medicine, not Harvard Medical School. Because of an editing error, the earlier version also misstated the dates of Dr. Relman’s tenure as editor of The New England Journal of Medicine. He held the post from 1977 to 1991, not from 1977 to 2000. (Dr. Angell was editor in 1999 and 2000.)

BBC Start The Week: Thinking about new forms of Government

Compelling discussion about new thinking about, and forms of government…

http://www.bbc.co.uk/podcasts/series/stw

Tristram Hunt, Adrian Wooldridge, Charu Lata Hogg and Anjan Sundaram

Mon, 9 Jun 14

Duration:
42 mins

Tom Sutcliffe discusses whether Western states have anything to learn from countries like China and Singapore. Adrian Wooldridge argues that many governments have become bloated and there’s a global race to reinvent the state. In the past Britain was at the forefront of exporting ideas on how to run a country, as the Labour MP Tristram Hunt explains in his book on the legacy of empire. Charu Lata Hogg from Chatham House looks at the challenges to democracy in Thailand where the country is in political turmoil, and the journalist Anjan Sundaram spent a year in The Congo during the violent 2006 elections, and looks at day-to-day life in a failing state.

End of medicare?

Excellent summary of the early 2014 state of play in health policy replete with solid historical perspective from Anne-marie and Jim Gillespie.

 

http://www.smh.com.au/federal-politics/political-news/is-this-the-end-of-medicare-20140609-39t2b.html

Is this the end of Medicare?

Date

A national institution, Medicare turns 40 this year. But are budgetary changes such as the doctor co-payment the beginning of the end for universal healthcare? Michael Green reports.

Victorian Aboriginal Health Service chief executive Jason King, clinical program manager Andrew Baker and medical director Mary Belfrage.

Victorian Aboriginal Health Service chief executive Jason King, clinical program manager Andrew Baker and medical director Mary Belfrage. Photo: Eddie Jim

Medicare was always a dogfight. It became law in the most extraordinary circumstances: one of a handful of bills passed during the only joint sitting of Federal Parliament in the nation’s history, after the double dissolution election in 1974.

As the Whitlam government prepared to introduce the system – then known as Medibank – its opponents rallied. The Australian Medical Association marshalled a million-dollar ”Freedom Fund”, donated by members. Determined to stop bureaucrats interfering with patients, it hired a former Miss Australia to front its publicity campaign. The General Practitioners’ Society of Australia circulated a poster depicting social security minister Bill Hayden dressed in Nazi uniform.

Dr Anne-marie Boxall, co-author of Making Medicare, says Whitlam had little support, even from within the Labor Party. The party platform advocated a fully nationalised model, along the lines of the British National Health System. By contrast, Whitlam’s plan was for a public insurance scheme. Health services would be delivered by a mix of public and private providers, paid for by taxpayers and guaranteed for everyone.

”The crucial members of his caucus didn’t agree with him, but he was adamant,” she says. ”He’d done a lot of thinking about it. So he waged the war of public opinion and he won. It’s an amazing political story.”

Medibank began full operation on October 1, 1975, just six weeks before the dismissal of the Whitlam government. The Fraser government tinkered with the system several times before abolishing it – only for it to be revived by the Hawke government in 1984 in almost exactly the same form.

Thirty years later, Medicare enjoys overwhelming public support. Politicians will swear to defend its honour, no matter their stripes or the system’s shortcomings. And yet, in the wake of the federal budget, many people believe Medicare is under threat. The target of most ire is the proposed co-payment for doctor visits, under which even the poorest will have to pay for up to ten appointments each year.

Are these changes the beginning of the end of universal coverage? Or another nail in its coffin? Or are they actually a distraction from the deeper afflictions at the heart of Australia’s healthcare system?

Health Minister Peter Dutton describes the Coalition as ”the greatest friend Medicare ever had”. The Coalition has demonstrated its amity with a host of announcements, including the co-payment, which also affects diagnostic tests and prescription drugs. (These charges will be capped for children, low-income earners and the chronically ill.)

More people will pay the Medicare levy surcharge, and fewer will qualify for the private health insurance rebate. Billions of dollars have been cut from public hospitals, and the preventive health agency and other health promotion programs have been shut down. The savings will be directed to a medical research fund.

Dutton says that without these reforms, spiralling costs will jeopardise Medicare’s viability. ”The government is very keen to keep Medicare and strengthen it. To keep it universal, we have to make sure it’s affordable. In my view, Medicare is only sustainable if those people who have a capacity to pay contribute to the system.”

However, Professor John Deeble, one of the original scheme’s architects, says while costs have been rising, they’re manageable. Health spending by our governments is low compared with other wealthy countries. The Coalition’s planned changes, he says, are not really about the sustainability of Medicare. ”They just want to spend the money on something else, simple as that.”

The Medicare levy (currently 1.5 per cent of an average income) was introduced to help fund a universal healthcare scheme. If our health costs rise, the government can raise the levy, Deeble says. In that way, people’s contributions are determined by their capacity to pay – their income – not by how often they need treatment. By introducing co-payments instead, the government is embracing something fundamentally different: a ”user-pays” notion of fairness in health funding.

In Medicare’s first incarnation, when social security minister Bill Hayden introduced the bill to Parliament, he declared that its three motivating principles were ”social equity, universal coverage and cost efficiency”.

Although the full details of the Coalition’s reforms haven’t been released, public health experts have been unanimous: as a package, it’s simply bad policy.

”We’ve actually tried all these solutions before, which is why we know they don’t work,” says Boxall, who is the director of the Deeble Institute for Health Policy Research. ”We need to step back and look at the structural problems with our health system.”

Two key problems were unforeseen at the time of Medicare’s design: the rise of private healthcare, and the growing burden of chronic illnesses. ”Things have changed,” Boxall says. ”So what are we doing to improve universality, equity and efficiency?”

For most of the 20th century, Australia had a two-tier medical system: a very basic insurance system for the working class and a fee-paying model for those who could afford it. ”Doctors offered quite different services, and in many cases different waiting rooms for each group,” says Associate Professor James Gillespie, from the University of Sydney’s school of public health, co-author of Making Medicare.

The World Health Organisation says ”universal coverage” means ”all people have access to services and do not suffer financial hardship paying for them”.

But under Medicare, we’re already failing the equity test. More than one-in-six Australians say they don’t see a doctor or fill prescriptions because of the cost, according to an international study published by the journal Health Affairs. Other research has shown that people who live in poorer neighbourhoods are more likely to delay medical care.

Even without co-payments, Australian patients fork out a lot for treatment from their own pockets, compared with other developed countries. The two-tier system has re-emerged. One reason, says Gillespie, is that ”both sides of politics have refused to think seriously about the role of the private system”. Major reviews commissioned by both the Howard and Rudd governments specifically avoided examining its role.

When Medicare began, private hospitals were a small industry, run by churches and charities. But in the past two decades they’ve become a big business, where doctors earn much more.

Until the 1990s, private health insurance was in terminal decline. But spurred on by the Howard government’s incentives – the Medicare levy surcharge and lifetime cover discount – just under half the population now has private cover. ”We’ve ended up with a private system that shifts services away from the public and creates more privileged ways of doing things,” says Gillespie.

He says private funding can contribute to universal care, so long as core services are delivered the same way to everyone. Canada has a similar system to ours, but private insurance isn’t allowed to cover the services offered by its public system. ”If there’s a different system for those who can afford better, you end up with a residual service, which gets squeezed and becomes second best,” he says.

The Coalition argues the co-payment is a ”price signal” to alert people to the real cost of treatment. But there’s something unusual about healthcare – even economists say so. In simple terms: you can judge how you’ll feel if you forgo buying a hamburger, but not if you forgo visiting the doctor.

”In the case of healthcare, part of the product itself is giving you that information,” explains Professor Jeff Richardson, from Monash University’s centre for health economics. ”You’re not in a position to judge what life would be like with and without it.” All of which means that promoting efficiency is more complex than imposing a price signal.

Australia’s health costs have been rising, but compared with other OECD countries our total health spending – both private and public – is just below average. It’s half that of the United States, as a percentage of GDP.

”When the government says Medicare is unsustainable, it’s lying,” Richardson says. ”The Australian government could spend much more on health if it wished. It’s simply a political and social judgment that it doesn’t want to.”

Curiously, despite Dutton’s warnings about unsustainable health spending, his reforms – which aim to push more people into the private system – will end up costing more overall. When the government acts as our single-insurer under Medicare, it has the power and incentive to bargain hard: as a result of bulk billing, GPs incomes are low by international standards. But with many different payers – like in the US system – it’s easier for private insurers to increase fees than control costs.

And for now, GPs and pharmaceuticals are the most cost-effective parts of the health system. Increasing their price will push more patients into hospitals, which are much more costly.

The measures are not a question of efficiency, Richardson says, but rather an ideological choice that health is an individual responsibility, not a shared one, like defence or policing. ”If we swing over to the private sector and push it back on individuals, the health of poorer people will suffer and overall costs will almost certainly rise.”

Dutton, however, maintains the measures aren’t about ideology, citing the Hawke government’s plans to introduce a $2.50 co-payment for GP visits in 1991. (Paul Keating scrapped the idea as prime minister.) ”I strongly believe that the changes we’ve put forward will improve access and the standard of care provided by GPs,” Dutton says.

But the biggest challenge to the standard of care now comes from an entirely different source, one his reforms do nothing to address. Our greatest healthcare inefficiency is found in a disconnect between the system – the fragmented network of hospitals, specialists and GPs, and their mishmash of state, federal and private funding – and the kinds of illnesses we have.

Where once we suffered acute ailments, we now need ongoing support with chronic conditions, says Dr Steve Hambleton, outgoing president of the Australian Medical Association. The number of deaths from heart attacks, for example, peaked in the 1970s. But living with heart disease requires continual treatment and adjustment, especially as you develop other conditions.

Patients with chronic diseases need to see a variety of health professionals and have frequent tests – but they are often seeing them in a piecemeal way with little continuity or communication between experts. Many of these, such as physiotherapists, psychologists or dieticians, are excluded or receive only limited funding under Medicare.

Both parties have attempted limited reforms to address the rise of chronic illnesses. But Hambleton says: ”We need a proactive, long-term approach … supporting primary healthcare to keep patients out of hospitals, and make sure people don’t fall through the cracks when they move between community and hospital care.”

The wide hallway of the Victorian Aboriginal Health Service in Fitzroy is humming: people young and old are waiting and chatting. Some are on the go, others hovering around a wood heater. Today, a specialist is visiting to conduct an ear, nose and throat clinic.

Jason King, the centre’s CEO, says they offer an holistic service. There are GPs, dentists, visiting specialists, social workers and financial counsellors, all supported by Aboriginal health workers. ”It’s not pumping them out every ten minutes. It’s ‘How’s mum and dad going? How’s uncle going who lives with you?’ We’re the central hub, this is where people come and see family.”

Last year, the health service celebrated its 40th anniversary. Each year, about a third of the state’s Aboriginal population pass through its doors. The centre’s model of integrated care, embedded in the values of its community, is exactly what doctors and experts have ordered – along with the WHO, the OECD and several Australian inquires.

But King says the co-payment and cuts to preventive health will either cost the centre patients or take a chunk out of its budget. Either way, that means fewer services.

There are 28 Aboriginal community-controlled health centres around the state. Jill Gallagher, CEO of their peak body, says Aboriginal health remains worse than the rest of the nation. ”The life expectancy in Fitzroy is the same as the life expectancy in Fitzroy Crossing,” she says. ”For every dollar spent on Medicare for a non-Aboriginal person, about 60¢ is spent on Aboriginal people. Access to primary healthcare is still not equitable, in spite of the fact there’s four times the burden of illness in the Aboriginal community.”

Dr Mary Belfrage, the service’s medical director, says any barriers to accessing healthcare cause people to show up later, with advanced conditions, which are more expensive to treat. ”It all translates to worse health outcomes, but it’s also inefficient,” she says. ”This isn’t about party politics or a particular budget. It’s about the principle of equity and how it impacts on health.”

Duckett: Has health reform failed? Yes

A big issue for the health system in Australia is that no-one’s in charge. Not the Commonwealth, not the states, not the private health insurance funds. Most provision is private: general practitioners are increasingly employed by for-profit chains, and before that, small business people. They respond to incentives designed by the Commonwealth government.

http://theconversation.com/did-the-health-reform-process-fail-now-well-never-know-27921

Did the health reform process fail? Now we’ll never know

Abandoning health reforms will undoubtedly lead to worse performance, including longer waiting times, across the health system. AAP Image/Quentin Jones

Yesterday was a sorry day in the long history of health reform in Australia. The Council of Australian Governments (COAG) Reform Council issued its five year score-keeper’s report on health reform progress. It will be the last such report, since the COAG Reform Council has been sacrificed on the altar of savings in the May budget, and we will no longer know how our governments are performing.

The COAG Reform Council paints some lipstick on the pig but overall reform results are poor in the health system. Compared to last year, Australians are waiting marginally longer for elective surgery, longer for community support in the home, and dramatically longer to get into residential aged care.

On the upside, we’re living slightly longer, having fewer heart attacks and the incidence of some cancers has reduced. The five-year trends for performance paint a similar picture to the year-on-year results.

It’s easy to conclude that the health reform process was a waste of time and money. But this is shortsighted. Many of the structural reforms focused on building the foundations of a health system that was on the verge of being able to deliver real improvements in patient care.

Slow road to reform

Kevin Rudd’s gab-fest of health reform talk in 2009 and early 2010 led to an alphabet soup of new health agencies, some investment in parts of the health system, more data in the public domain than we’ve ever seen but precious little in terms of real on-the-ground improvements.

But there were some important exceptions. The Rudd-appointed National Health and Hospitals Reform Commission identified a gap in availability of rehabilitation beds in the system. Without adequate rehabilitation care people were ending up in nursing homes when they could have been at home. Reform money helped to address that gap, although that funding was abruptly terminated in the 2014 budget.

Funding was also provided for better prevention programs and to reward improvements in waiting times where they occurred. Medicare Locals were created to provide a platform for improvements in primary care such as better after-hours services.

Running a health system is hard, improving it is even harder. But we have to improve every day just to stand still. The new treatments that are introduced every week put pressure on the health dollar. These new treatments, though, mean we’re living longer – so we get something for the extra money.

A big issue for the health system in Australia is that no-one’s in charge. Not the Commonwealth, not the states, not the private health insurance funds. Most provision is private: general practitioners are increasingly employed by for-profit chains, and before that, small business people. They respond to incentives designed by the Commonwealth government.

The pathology and radiology markets are also highly concentrated corporatised businesses. Around one-third of hospital beds are in private hospitals, and most of those are for-profit businesses as well.

Abolishing the foundations

The health reform process mainly concentrated on two aspects of the system: primary care and public hospitals. Primary care reform was mainly effected through the creation of Medicare Locals and GP Super Clinics.

Both were good ideas but flawed in implementation: some Super Clinics are still not open five years after the policy got underway. Medicare Locals were over-hyped by the previous government, wrapped up in red tape by the Commonwealth Health Department and as a result of the budget are being abolished and replaced by new organisations.

Public hospital reform had two elements. In most states it included increased local autonomy through introduction of local boards, and increased services with expanded rehab being the best example. At the national level it included a new alignment of Commonwealth and state interests in controlling hospital costs.

From June 1, 2014, the Commonwealth will meet 45% of the costs of increased hospital activity, but only up to an independently determined “efficient price”. This is a good reform, because could have ended the blame game between Commonwealth and states over money by locking the former into funding increased health state health spending. But these changes will be undone in 2017.

So come 2017, most evidence of health reform will have vanished. There will be some ongoing structures and services, but the big aspirations to address the big problems will have fizzled out.

The problems won’t go away, however. Innovation and system reform will still be required. If anyone is around to issue the next score-keeper’s report it will undoubtedly show worse performance, including longer waiting times, across the health system. There’ll then be more calls for reform and the whole cycle will start again, but with wasted years in the meantime.

Scruitiny starts to land in healthcare…

“When hospital administrators meet with doctors, we talk in great platitudes, and it’s easy for physicians to say, ‘Well, my patients are sicker.’ Data takes out the emotion. It can be a moment of shock.

They key to delivering information unemotionally is using a physician leader as the messenger. 

“The important mental transition that has to occur within physicians is, ‘This is about a team concept and approach to care. It’s not just about me and why I think is best for my patient.’ That’s a problem some physicians have.”

http://www.healthleadersmedia.com/print/PHY-305709/Physicians-Feel-Reforms-Tight-Scrutiny

Physicians Feel Reform’s Tight Scrutiny

Jacqueline Fellows, for HealthLeaders Media , June 19, 2014

Thanks to healthcare reform, there are now more eyes on how doctors treat their patients and more opinions on how they should be treating them. But one physician leader says the pressure doesn’t necessarily mean that doctors have to be on the defensive.

All working professionals, from writers to physicians, have a preference for the way their work gets done, but a doctor’s penchant for how he or she cares for a patient is increasingly coming under scrutiny.

First, there are cost and quality pressures from hospitals, health systems, and payers as a result of the value-based healthcare transition that affects how physicians practice, not to mention public pressure on how much physicians get paid with the recent release of Medicare payment data.

Then there are the efforts to standardize patient care among providers in hospitals, group practices, and health systems in an effort to improve quality.

All of it leads to more eyes (and opinions) on how doctors care for patients, which can be uncomfortable.

Kevin Wheelan, MD, chief of staff and co-medical director of cardiology for Baylor Heart and Vascular Hospital, a joint venture hospital within Dallas-based Baylor Scott & White Health, says the pressure doesn’t necessarily mean that doctors have to be on the defensive, or have an adversarial relationship with leaders.

Rather, Wheelan looks at the issue through a different lens. Without uniformity of care, quality can suffer, and patients leave confused. “Ten different sets of discharge instructions sets up [the hospital] for inconsistency,” he says. “If the patient doesn’t leave the hospital with a well-articulated game plan, that could lead to an unscheduled visit to the ER.”

That’s code for readmissions and possible penalties. Reducing both requires better communication with the patient, which Wheelan says has improved at BHVH with better and easier-to-understand discharge instructions.

“The tools have improved in terms of more detailed collateral materials as a resource for patients to refer back to,” says Wheelan.

In addition, Wheelan says BHVH has also enhanced medication reconciliation by having both a nurse and a physician review what medicine a patient is taking at home that could interfere with medication prescribed upon release.

The post-discharge appointment is also a more focused discussion, says Wheelan.

“Instead of telling a patient, ‘See you within 30 days,’ for example, the goal is to have a follow up appointment scheduled, so it’s not a nebulous concept of when they’re returning.”

Follow-up phone calls also help reduce readmissions and anxiety from patients. The phone calls are also a data mining exercise that shows variance among physicians. It’s not intended to be an exercise in checking up on physicians, but it has helped standardize care and reinforce a culture of teamwork.

“We keep track of all of these phone calls,” says Wheelan. “We have a document typed up, blinded to the patients’ names, and those results are provided back to the physician leader and the physician practices for an opportunity for improvement issue.”

Using data to show a variance can take some of the sting out of a difficult conversation with a physician. It helps, says Wheelan, that physicians see exactly what a patient is saying.

“It gives [physicians] a different insight,” he says. “The doctors get to see types of concerns the patients have.”

Wheelan says BHVH’s system isn’t not perfect. There are still difficulties with weekend discharges, but he says setting a specific follow-up appointment time is the biggest change since BHVH opened in 2002. But it didn’t happen easily because of physician preference.

“It’s an issue of compromise,” says Wheelan. “You have a group of physicians who say, ‘I need to see a patient two days post-op,’ and another group who says they need five days. So we have to come to an agreement that we will see the patient within 2–5 days.”

Getting standardization among physicians is difficult, admits Wheelan, but it’s also an opportunity for physician leaders to emerge because “someone has to be a champion,” willing to track down the other physicians and get buy in for clinical protocols.

Using data to accompany a potentially hard conversation about performance is an approach that is also used at Southwest General Health Center, a 354-bed hospital in Middleburg Heights, OH.

“Physicians tend to be logical, numbers-driven people,” says Jill Barber, director of managed care operations and revenue integrity for Southwest General. “When hospital administrators meet with doctors, we talk in great platitudes, and it’s easy for physicians to say, ‘Well, my patients are sicker.’ Data takes out the emotion. It can be a moment of shock.”

Also like BHVH, Southwest General uses verbatim comments from patients to give physicians insight into patient satisfaction. “By sharing with them the actual comments, it brings it home,” says Barber.

They key to delivering information unemotionally is using a physician leader as the messenger. It’s what BHVH and Southwest General rely on because it is peer-to-peer, and more “collegial” rather than punitive, says Barber.

Physicians also have to think differently in a value-based era of healthcare, explains Wheelan.

“The important mental transition that has to occur within physicians is, ‘This is about a team concept and approach to care. It’s not just about me and why I think is best for my patient.’ That’s a problem some physicians have.”

It’s a problem they’ll likely have to grow out of, too, in order to withstand the pressure, opinions, and eyes that are watching.


Jacqueline Fellows is an editor for HealthLeaders Media.

Cth Fund Country Comparisons

 

http://www.commonwealthfund.org/publications/fund-reports/2014/jun/mirror-mirror

PPT: Exhibit_ES1_CthFund

Mirror, Mirror on the Wall, 2014 Update: How the U.S. Health Care System Compares Internationally

Executive Summary

The United States health care system is the most expensive in the world, but this report and prior editions consistently show the U.S. underperforms relative to other countries on most dimensions of performance. Among the 11 nations studied in this report—Australia, Canada, France, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland, the United Kingdom, and the United States—the U.S. ranks last, as it did in the 2010, 2007, 2006, and 2004 editions of Mirror, Mirror. Most troubling, the U.S. fails to achieve better health outcomes than the other countries, and as shown in the earlier editions, the U.S. is last or near last on dimensions of access, efficiency, and equity. In this edition of Mirror, Mirror, the United Kingdom ranks first, followed closely by Switzerland (Exhibit ES-1).

Expanding from the seven countries included in 2010, the 2014 edition includes data from 11 countries. It incorporates patients’ and physicians’ survey results on care experiences and ratings on various dimensions of care. It includes information from the most recent three Commonwealth Fund international surveys of patients and primary care physicians about medical practices and views of their countries’ health systems (2011–2013). It also includes information on health care outcomes featured in The Commonwealth Fund’s most recent (2011) national health system scorecard, and from the World Health Organization (WHO) and the Organization for Economic Cooperation and Development (OECD).

Overall health care rankingClick to download Powerpoint chart.

The most notable way the U.S. differs from other industrialized countries is the absence of universal health insurance coverage.5 Other nations ensure the accessibility of care through universal health systems and through better ties between patients and the physician practices that serve as their medical homes. The Affordable Care Act is increasing the number of Americans with coverage and improving access to care, though the data in this report are from years prior to the full implementation of the law. Thus, it is not surprising that the U.S. underperforms on measures of access and equity between populations with above- average and below-average incomes.

The U.S. also ranks behind most countries on many measures of health outcomes, quality, and efficiency. U.S. physicians face particular difficulties receiving timely information, coordinating care, and dealing with administrative hassles. Other countries have led in the adoption of modern health information systems, but U.S. physicians and hospitals are catching up as they respond to significant financial incentives to adopt and make meaningful use of health information technology systems. Additional provisions in the Affordable Care Act will further encourage the efficient organization and delivery of health care, as well as investment in important preventive and population health measures.

For all countries, responses indicate room for improvement. Yet, the other 10 countries spend considerably less on health care per person and as a percent of gross domestic product than does the United States. These findings indicate that, from the perspectives of both physicians and patients, the U.S. health care system could do much better in achieving value for the nation’s substantial investment in health.

Major Findings

  • Quality: The indicators of quality were grouped into four categories: effective care, safe care, coordinated care, and patient-centered care. Compared with the other 10 countries, the U.S. fares best on provision and receipt of preventive and patient-centered care. While there has been some improvement in recent years, lower scores on safe and coordinated care pull the overall U.S. quality score down. Continued adoption of health information technology should enhance the ability of U.S. physicians to identify, monitor, and coordinate care for their patients, particularly those with chronic conditions.
  • Access: Not surprisingly—given the absence of universal coverage—people in the U.S. go without needed health care because of cost more often than people do in the other countries. Americans were the most likely to say they had access problems related to cost. Patients in the U.S. have rapid access to specialized health care services; however, they are less likely to report rapid access to primary care than people in leading countries in the study. In other countries, like Canada, patients have little to no financial burden, but experience wait times for such specialized services. There is a frequent misperception that trade-offs between universal coverage and timely access to specialized services are inevitable; however, the Netherlands, U.K., and Germany provide universal coverage with low out-of-pocket costs while maintaining quick access to specialty services.
  • Efficiency: On indicators of efficiency, the U.S. ranks last among the 11 countries, with the U.K. and Sweden ranking first and second, respectively. The U.S. has poor performance on measures of national health expenditures and administrative costs as well as on measures of administrative hassles, avoidable emergency room use, and duplicative medical testing. Sicker survey respondents in the U.K. and France are less likely to visit the emergency room for a condition that could have been treated by a regular doctor, had one been available.
  • Equity: The U.S. ranks a clear last on measures of equity. Americans with below-average incomes were much more likely than their counterparts in other countries to report not visiting a physician when sick; not getting a recommended test, treatment, or follow-up care; or not filling a prescription or skipping doses when needed because of costs. On each of these indicators, one-third or more lower-income adults in the U.S. said they went without needed care because of costs in the past year.
  • Healthy lives: The U.S. ranks last overall with poor scores on all three indicators of healthy lives—mortality amenable to medical care, infant mortality, and healthy life expectancy at age 60. The U.S. and U.K. had much higher death rates in 2007 from conditions amenable to medical care than some of the other countries, e.g., rates 25 percent to 50 percent higher than Australia and Sweden. Overall, France, Sweden, and Switzerland rank highest on healthy lives.

Summary and Implications

The U.S. ranks last of 11 nations overall. Findings in this report confirm many of those in the earlier four editions of Mirror, Mirror, with the U.S. still ranking last on indicators of efficiency, equity, and outcomes. The U.K. continues to demonstrate strong performance and ranked first overall, though lagging notably on health outcomes. Switzerland, which was included for the first time in this edition, ranked second overall. In the subcategories, the U.S. ranks higher on preventive care, and is strong on waiting times for specialist care, but weak on access to needed services and ability to obtain prompt attention from primary care physicians. Any attempt to assess the relative performance of countries has inherent limitations. These rankings summarize evidence on measures of high performance based on national mortality data and the perceptions and experiences of patients and physicians. They do not capture important dimensions of effectiveness or efficiency that might be obtained from medical records or administrative data. Patients’ and physicians’ assessments might be affected by their experiences and expectations, which could differ by country and culture.

Disparities in access to services signal the need to expand insurance to cover the uninsured and to ensure that all Americans have an accessible medical home. Under the Affordable Care Act, low- to moderate-income families are now eligible for financial assistance in obtaining coverage. Meanwhile, the U.S. has significantly accelerated the adoption of health information technology following the enactment of the American Recovery and Reinvestment Act, and is beginning to close the gap with other countries that have led on adoption of health information technology. Significant incentives now encourage U.S. providers to utilize integrated medical records and information systems that are accessible to providers and patients. Those efforts will likely help clinicians deliver more effective and efficient care.

Many U.S. hospitals and health systems are dedicated to improving the process of care to achieve better safety and quality, but the U.S. can also learn from innovations in other countries—including public reporting of quality data, payment systems that reward high-quality care, and a team approach to management of chronic conditions. Based on these patient and physician reports, and with the enactment of health reform, the United States should be able to make significant strides in improving the delivery, coordination, and equity of the health care system in coming years.

us health care ranks last

Selecting health insurance based on value of care covered…

A solid idea.

Allowing consumers to pick how “fruity” they want their cover to be. This takes self-serving autonomy from the clinicians and places it back with the patients, who no longer have to cross-subsidise silly, exorbitant care.

 

http://www.nytimes.com/2014/06/10/upshot/how-to-pay-for-only-the-health-care-you-want.html

Photo

CreditMagoz
One reason health insurance is expensive is that most plans cover just about every medical technology — not just the ones that work, or the ones that are worth the price. This not only drives up costs, but also forces many Americans into purchasing coverage for therapies they may not value. But there’s no reason things couldn’t be different, and better for consumers.

Consider the latest technology for treating prostate cancer: the proton beam. It’s delivered with a football field-size machine costing well over $100 million. Per treatment, this therapy costs at least twice as much as alternative approaches, but is no more effective. Many health plans cover it and other therapies of low or uncertain value because they pay for anything that physicians deem medically necessary even when evidence suggests otherwise. And, without even knowing it, Americans pay for it in higher premiums.

It doesn’t have to be this way. If plans could compete on the basis of the therapies they cover, consumers could decide what they wish to pay for. This sounds complicated, but it need not be.

Health plans could define themselves at least in part by the value of technologies they cover, an idea proposed by Professor Russell Korobkin of the U.C.L.A. School of Law. For example, a bronze plan could cover hospitalizations and visits to doctors for emergencies and accidents; genetic diseases; and prescription drugs that keep people out of hospitals. A silver plan could cover what bronze plans do but also include treatments a large majority of physicians find useful. A gold plan could be more inclusive still, adding coverage, for instance, for every cancer therapy shown to improve patient outcomes (no matter the cost) as long as it was delivered at a leading cancer center. Finally, a platinum plan could cover experimental and unproven cancer therapies, including, for example, that proton beam.

This way, nothing would be concealed or withheld from consumers. Someone who wanted proton-beam cancer treatment coverage could have it by selecting a platinum policy and paying its higher premiums. Someone who did not want to pay higher premiums for lower-value care, in turn, could choose a bronze or silver plan. This gives a different, but more useful, meaning to the terms “gold,” “silver” and “bronze” than they have in the new insurance exchanges today.

A second concern is that as people become sick, they will prefer plans that cover more treatments, including experimental ones. As sick people disproportionately choose more generous plans, their expenses and premiums will have to rise. This phenomenon, known as adverse selection, is familiar in most health insurance markets, including those for employer-sponsored plans, private plans that participate in Medicare and in the Affordable Care Act’s new marketplaces. One common way to address it is to permit individuals to switch plans only once per year, during an open enrollment period. This locks people into their choice for some time, so they can’t suddenly upgrade their plan after getting sick. If a once-per-year enrollment period proves insufficient in this case, a longer period could be imposed.

Structuring health plans according to value would give Americans the ability to buy whatever health care technologies they choose — including, if they want it, unproven and expensive care — without forcing others to pay for that choice. This would help address the key, though under-recognized, problem in American health care today: not that Americans spend a lot on health care, but that they spend a lot without always getting good value for the money.